Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Up 0.9 %

Shares of NYSE:RVP opened at $1.07 on Thursday. The company has a fifty day moving average of $1.18 and a 200-day moving average of $1.16. The company has a market capitalization of $32.04 million, a PE ratio of -4.46 and a beta of 2.11. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.41 and a current ratio of 8.28. Retractable Technologies has a 52-week low of $0.95 and a 52-week high of $1.85.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Retractable Technologies stock. WealthTrust Axiom LLC lifted its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 126,533 shares of the company’s stock after buying an additional 27,500 shares during the period. WealthTrust Axiom LLC owned about 0.42% of Retractable Technologies worth $151,000 as of its most recent SEC filing. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.